Clinical Trials Logo

CNV clinical trials

View clinical trials related to CNV.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04575350 Completed - Genetic Disease Clinical Trials

Reinterpretation of CNV With Unknown Significance: a 5-year Retrospective Analysis

ReAC
Start date: January 1, 2019
Phase:
Study type: Observational

We aim to assess the usefulness of systematic reinterpretation of CNV of unknown significance. To investigate this question we will study all CNV of unknown significance detected between 2010 and 2017.

NCT ID: NCT01570790 Completed - Clinical trials for Age-related Macular Degeneration

Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration

Start date: May 2003
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the study is assess safety, bioactivity, and maximal tolerated dose of repeated weekly intravenous infusion of combretastatin A-4 phosphate (CA4P) in patients with neovascular age-related macular degeneration

NCT ID: NCT00564291 Completed - Macular Edema Clinical Trials

Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT)

Start date: January 2007
Phase:
Study type: Observational

Comparison of different OCT instruments to assess retinal thickness, correlation to fluorescein angiography, and visual outcome after therapy with anti-VEGF therapy